General Information
The federal securities laws prohibit individuals with access to material information which has not been publicly disseminated, absorbed and evaluated (commonly referred to as “inside information”) from: (1) engaging in transactions in the Company’s securities unless the Company has disclosed such information; or (2) divulging inside information to enable others to trade on such information. As employees or members of the Board of Directors, you may come into possession of inside information. Except with respect to a transaction pursuant to a Rule 10b5-1 Plan, if you effect transactions in the Company’s securities while in the possession of inside information, then you, and possibly the Company, will be subject to private lawsuits for damages or to civil or criminal proceedings by the Securities and Exchange Commission (“SEC”). Liability arising from such violations is often significant. For instance, the SEC is authorized to seek civil money damages of up to three times the profit gained or loss avoided through unlawful insider trading.

Disclosure Guidelines
In discussing matters pertaining to the Company, employees and members of the Board of Directors should comply with the following guidelines:

1. Matters that you may discuss include the following:

(a) Information that has been published and widely disseminated, such as that contained in the Company’s annual report to shareholders, reports on Form 10-K and 10-Q, proxy statements and press releases, so long as you limit your discussion to the information that has been published and disseminated.

(b) General industry and economic trends.

(c) Routine aspects of the Company’s business involving products, plants, employees, customers and production.

Requests and questions from investors, analysts, the press, or other outsiders should be referred to either Kevin Veltman, Treasurer, or to the General Counsel (each a “Monitor” and together the “Monitors”).

2. Matters that you may not discuss outside the Company, except to the extent the Company has publicly announced and widely disseminated them, include any of the following:

(a) Actual or projected sales, earnings, significant capital expenditures or significant borrowings.

(b) Any action or event that had or is likely to have a significant effect on the Company's anticipated annual sales or earnings or that may result in a special or extraordinary charge against earnings.

(c) Any non-routine action or event such as a proposed joint venture, merger, acquisition or disposition of shares or assets; major new products, discoveries or services; a change in control or a significant change in management; major financing; significant litigation; a significant change in capital investment plans; significant change in operating or financial circumstances; significant labor disputes; significant layoffs; a tender offer for another company’s securities; and significant changes in the Company’s asset values, products or lines of business.

As an additional reminder, any of the types of prohibited information described above that may come to your attention regarding other companies because of the Company’s special relationship with that company should not be publicly disclosed. Any questions should be referred to a Monitor.

Trading Prohibitions and Guidelines
While investment in the Company’s securities is encouraged, you should effect transactions in the Company’s securities with caution. In the case of the Board of Directors and executive officers, such transactions require prior Company approval in the manner described below under "Additional Rules Applicable to Form 4 Filers – Pre- Transaction Review". Before you effect transactions in the Company’s securities, you should recognize the existence of prohibitions against the use by corporate insiders of inside information for their own profit.

Prohibitions and guidelines in paragraph 1 below are applicable to all employees and members of the Board of Directors when dealing in the Company’s securities. The items described in paragraphs 2 through 5 below are applicable only to employees at the director level and above and members of the Board of Directors.

  1. Transactions involving the Company’s securities are prohibited at all times if you have knowledge of material information about the Company that the Company has not publicly disseminated. In general, information should be considered “material” if it could be expected that a reasonable investor would attach significance to the information in reaching an investment decision involving the Company’s securities. Determining whether information is material is subjective; accordingly, employees should discuss such issues with a Monitor or other designated Company personnel. Transactions in the Company’s securities are prohibited until the close of the second full trading day after public disclosure of material information.
  2. Transactions in the Company’s securities are prohibited starting three (3) weeks before the end of any fiscal quarter and ending at the close of the second full trading day after public release of the Company’s quarterly or annual financial results.
  3. Transactions in the Company’s securities are prohibited during periods that the Company has designated as a limited trading period unless the director or employee obtains the prior approval of a Monitor. For example, limited trading periods would occur if you have knowledge that the Company is involved in negotiations for the acquisition of a significant business or there is a blackout on the pension or profit-sharing plan trading Company securities.
  4. Directors and employees are not prohibited from exercising stock options during any of the foregoing periods, but the options must be exercised by paying cash for the exercise price and tax withholding and the shares received must be held during the period in which trading is prohibited.
  5. During all other times, employees are not prohibited from trading in the Company’s securities, unless they have inside information. However, the Board of Directors and executive officers are subject to the procedures described below under “Adoption of Rule 10b5-1 Plans”.
  6. Paragraphs 1-5 above and paragraph 1 below under " Additional Rules Applicable to Form 4 Filers" do not apply to Company securities sold or purchased by a director or executive officer pursuant to a plan adopted pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934 (a "10b5-1 Plan") if such Plan has been approved by a Monitor and if the director or executive officer adopting such plan has provided a signed copy of such Plan to a Monitor within ten (10) days after adoption.

Adoption of Rule 10b5-1 Plans
The adoption of a 10b5-1 Plan is not required for all sales of Company securities. The following transactions do not require the adoption of a 10b5-1 Plan (but are otherwise subject to the prohibitions and guidelines above):

  1. Exercising options and holding the net shares.
  2. Sales of stock to cover taxes on vesting of shares and exercise price and taxes for exercising options.
  3. Cumulative stock sales of less than 10% of the holdings of the director or executive officer within any 12-month period.
  4. Stock gifted to 501(c)(3) qualified charitable organizations.

If a director or executive officer or director intends to dispose of Company securities beyond the safe harbors set forth above (including reducing his or her holdings of Company securities below the applicable ownership guidelines to diversify investments in anticipation of retirement), the employee or director shall present his or her proposed sales of Company securities to the CEO, who may consult with counsel and the chairman of the Executive Compensation Committee, and who will determine whether the prospective sales will be permitted and whether or not a 10b5-1 Plan must be adopted.

Additional Rules Applicable to Form 4 Filers
Section 16 of the Securities Exchange Act of 1934 applies to all members of the Board of Directors, executive officers, and their families ("insiders"). Section 16(b) provides that any profit realized by any insider from any combination of a purchase and sale or sale and purchase of any of the Company’s equity securities within any six-month period is recoverable by the Company. Liability is imposed under Section 16(b) regardless of intent or possession or use of inside information. Further, the Company may not waive its right to recover this “profit.”

Section 16(a) requires that insiders file reports of most transactions in the Company’s securities with the SEC within two (2) business days of each transaction. Transactions for reporting purposes include any change in ownership, including option grant, stock grant, or exercise of options.

To avoid any liability to the Company under Section 16(b) and to assist in the timely filing of transaction reports under Section 16(a), we require that insiders adhere to the following guidelines:

  1. Pre-Transaction Review. Prior to consummating any transaction in the Company’s securities, members of the Board of Directors and executive officers designated by the Board must obtain preclearance from a Monitor. This pre-transaction review will help insure any necessary compliance with Rule 144, assist in the preparation of required reports, and avoid inadvertent insider trading violations. Notice of an intention to purchase or sell must be given to a Monitor, or in their absence to Angela Shamery or Julie DeShaw, at least two (2) days before any transaction. If a Monitor approves the transaction, then an e-mail approving the transaction will be sent in response.
  2. Preparation of Required Reports. While the Company will assist an employee in the preparation and filing of Form 4 and 5 Reports, the ultimate legal responsibility for the accuracy and filing of these reports remains with the employee or director. The Treasury Department (Angela Shamery) will prepare any Form 3 upon an individual’s assumption of director or officer status. Thereafter, the Treasury Department will prepare a Form 4 upon notification that you have acquired or disposed of the Company’s securities. The report will be sent to the SEC electronically and will be executed through a power of attorney if the power of attorney has been supplied.

    It is mandatory to file Forms 4 and 5 via the SEC’s EDGAR filing system. Employees or directors should inform the Treasury Department of their desire to execute a standing power of attorney to give the Company the authority to sign a Form 4 or 5 to facilitate required filings and/or whether the employee would like to handle the EDGAR filing process themselves. Please note that Form 4 Reports are required to be filed within two (2) days following the transaction. All transactions including gifts are now required to be reported. Form 5 Reports are required to be filed within forty-five (45) days of the end of the Company’s fiscal year.
  3. Checklist. In addition to pre-clearing your transaction with a Monitor, before proceeding with the acquisition or disposition of any of the Company’s securities, please review the following checklist.

(a) If a sale is proposed by you or any member of your immediate family, make sure that:

(i) Neither you nor any member of your immediate family has made any purchases of the Company’s stock (or securities convertible into the Company’s stock) within the past six months;

(ii) No purchases by you or any member of your immediate family are anticipated within the next six months; and

(iii) Neither you nor any member of your immediate family has been granted any stock or options (except for stock or options granted under the Company’s Nonemployee Officer and Director Stock Option Plan or Long-Term Incentive Plan) within the past six months or will receive a grant within the following six months.

(b) If a purchase is proposed by you or any member of your immediate family, make sure that:

(i) Neither you nor any member of your immediate family has made any sales of the Company’s stock (or securities convertible into the Company’s stock) within the past six months; and

(ii) No sales are anticipated or required to be made within the next six months by you or any member of your immediate family.

4. Rule 144. In addition, members of the Board of Directors and executive officers will need to comply with the requirements of Rule 144 when selling any Company securities. This will include the preparation and filing of Form 144. A Monitor will assist you in complying with Rule 144.

5. Members of the Board of Directors and executive officers are prohibited from hedging the economic risk of their ownership of Herman Miller stock, including through the use of options or other derivatives related to our stock, and are prohibited from pledging Herman Miller stock.

Approved – March 2016; Updated – October 2018